UnknownNot Applicable

The Effect of the Motivational Interviewing Technique on Breast and Cervical Cancer Screenings

120 participantsStarted 2022-04-30

Plain-language summary

This study will be conducted to evaluate the effect of the motivational interviewing technique applied to menopausal women on their participation in breast and cervical cancer screenings. This is a randomized controlled intervention study in which the study sample will consist of 120 menopausal women, who visit the health care centers in the city of Kutahya. There will be one intervention group with a total of 60 participants and a control group with the same number of participants. The intervention group will have motivational interviews whereas the control group participants will follow the normal protocols.

Who can participate

Age range

69 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Visiting any family health centers in the city of Kütahya, * Without any cancer diagnosis and treatment, * Not having had a clinical breast examination in the last 1 year, with no natural menstrual period in the last 1 year, have entered menopause and are 69 years old (included) maximum, * Without a mammogram in the last 2 years in women who have gone through menopause and are 69 years old (included). * Without an HPV or Pap smear test in the last 5 years in women who have entered menopause and are in the age range of 65 (including), * Being literate, * Able to communicate. Exclusion Criteria: * Having been diagnosed with any cancer, * Inability to communicate, * Failure to continue the phases of the study for any reason.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Turkish Version of Champion's Health Belief Model Scale (CHBMS-T)

Timeframe: 4 Months Questions were answered on a 5-point Likert-type response scale ranging from 1 (strongly disagree) to 5 (strongly agree), and mean scores were computed for each subscale.

The Health Belief Model Scale for Cervical Cancer and the Pap Smear Test(HBMSCCPS)

Timeframe: 4 Months

Trial details

NCT IDNCT05353387

SponsorIstanbul Saglik Bilimleri University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-10-30

Contact for this trial

Tuğba ÖZTÜRK, PhD

+905305279492 tugba.ozturk@ksbu.edu.tr

View on ClinicalTrials.gov More Menopause trials